Edward E Graves
Affiliation: Harvard University
- Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planningE E Graves
Department of Radiology, University of California, San Francisco 94143, USA
Med Phys 28:2489-96. 2001..These images were sent via DICOM transfer to the treatment planning workstation. An analysis of the reproducibility of the..
- A submillimeter resolution fluorescence molecular imaging system for small animal imagingEdward E Graves
Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Med Phys 30:901-11. 2003..Finally, the in vivo imaging capacity is showcased. It is expected that the large dataset collected can enable superior imaging of molecular probes in vivo and improve quantification of fluorescence signatures...
- Fluorescence molecular imaging of small animal tumor modelsE E Graves
Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
Curr Mol Med 4:419-30. 2004..This technique offers the promise of non-invasively quantifying and visualizing specific molecular activity in living subjects in three dimensions...
- Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivoXiaojuan Li
Center of Functional and Molecular Imaging and Department of Radiology, University of California, San Francisco, CA 94107, USA
AJNR Am J Neuroradiol 26:760-9. 2005....
- Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presenceTracy R McKnight
Department of Radiology, Biostatistics Core, Comprehensive Cancer Center, University of California, San Francisco 94143, USA
J Neurosurg 97:794-802. 2002..The information gleaned from the biopsy correlation study was used to test the hypothesis that there is metabolically active tumor in nonenhancing regions of the T2-hyperintense lesion that can be detected using MR spectroscopy...
- In vivo tomographic imaging of near-infrared fluorescent probesVasilis Ntziachristos
Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Bldg 149 13th Street 5406, Charlestown, MA 02129 2060, USA
Mol Imaging 1:82-8. 2002..This validation of FMT with FRI demonstrated the spatial congruence of fluorochrome activation as determined by the two techniques...
- Singular-value analysis and optimization of experimental parameters in fluorescence molecular tomographyEdward E Graves
Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Room 5404, Charlestown, Massachusetts 02129, USA
J Opt Soc Am A Opt Image Sci Vis 21:231-41. 2004....
- Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopyAndrea Pirzkall
Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA 94143, USA
Int J Radiat Oncol Biol Phys 53:1254-64. 2002..We performed a study examining the impact MRSI would have on the routine addition of 2-3-cm margins around MRI T2-weighted hyperintensity to generate the treatment planning clinical target volume (CTV) for low-grade gliomas...
- Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancerViswam S Nair
Division of Pulmonary and Critical Care Medicine, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA
Cancer Res 72:3725-34. 2012..Together, our findings suggest that leveraging tumor genomics with an expanded collection of PET-FDG imaging features may enhance our understanding of FDG uptake as an imaging biomarker beyond its association with glycolysis...
- In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumorsMoritz F Kircher
Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA
Cancer Res 63:6838-46. 2003..Together, these results demonstrate that CLIO-HD is uniquely suited for quantitative repetitive MRI of adoptively transferred cells and that this approach may be particularly useful for evaluating novel cell-based therapies in vivo...